Search bioRxiv⌕ Search

Biology subjects

Blöchl, C.

Publications and source records attributed to Blöchl, C..

2 recordsLinked to original sources

Direct measurement and reconstruction of intact polyclonal IgG repertoires to preserve molecular and functional connectivity

Antibody function depends on the molecular pairing of antigen-binding Fab regions with Fc domains, linking antigen specificity to effector potential. However, antibody repertoire methods analyze these subunits separately, creating an inference problem in which Fc-Fab connectivity is lost. Here, we introduce a multi-level HPLC-MS workflow integrating native nanoflow cation-exchange chromatography-MS (nCEC-MS) of intact serum IgG with middle-up Fab and Fc/2 profiling. Native nCEC-MS reduces spectral congestion compared with denaturing reversed-phase HPLC-MS, enabling detection of 56-74 intact IgG mass features from 2 g of purified IgG per donor. Middle-up analysis provided complementary information on Fab diversity, subclass, and allotype, revealing donor-specific profiles. Reconstructing intact IgG1 masses from independently measured Fab and Fc/2 subunits partially recovers Fc-Fab molecular connectivity and supports interpretation of native intact mass features. Together, this framework provides an integrated view of the human IgG repertoire and establishes a foundation for studying its molecular topology in health and disease.

immunology↗

The NLRP3/eIF2 axis drives cell cycle progression in acute myeloid leukemia

Aberrant activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome mediates numerous inflammatory diseases. Oncogenes can activate the NLRP3 inflammasome and thereby promote myeloproliferative neoplasia, suggesting a crucial role of NLRP3 in the malignant transformation of hematopoietic cells. Here, we show that bone marrow-derived mononuclear cells of AML patients display enhanced expression of NLRP3, IL-1{beta} and IL-18 and that high-level expression of NLRP3 is linked to poor survival of AML patients. Pharmacological and genetic inhibition of NLRP3 inflammasome activation attenuated cell proliferation of MOLM-13 AML cells in vitro. In vivo, genetic inhibition of NLRP3 in MOLM-13 AML cells resulted in reduced engraftment potential in xenografts, along with reduced splenomegaly and organ infiltration. Differential proteomic analysis revealed the eIF2 pathway as potential target of NLRP3 in AML, with a significant increase of eIF2 phosphorylation upon NLRP3 inhibition. NLRP3 inhibition also caused a strong decrease in cyclin - dependent kinases CDK4 and CDK6, accompanied by an upregulation of the CDK inhibitor p21 (CDKN1A) and a marked arrest of cell cycle progression in the G0/G1 phase, consistent with the role of eIF2 phosphorylation as negative cell cycle regulator. Taken together, we show that inhibition of the NLRP3 inflammasome reduces AML cell proliferation by promoting eIF2 phosphorylation, which in turn enhances the expression of cell cycle arrest genes such as p21. Thus, the study uncovers the NLRP3/eIF2 axis as new driver of AML proliferation and proposes a novel therapeutic treatment of AML by targeted inhibition of NLRP3 activation.

immunology↗